FRANCE: FFR 544MN INVESTMENT FOR NOVARTIS PHARMA

Article Abstract:

The pharmaceutical group, Novartis Pharma, is going to install six production lines, for the manufacture of medicine against asthma and hay fever, in its biotechnology site in Huningue (Haut-Rhin). Production of this should reach one ton per year, as from 2002. The new production tools represent an investment of FFr 544mn.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

FRANCE: AVENTIS PHARMA INVESTS FFR 160MN IN LE TRAIT

Article Abstract:

Aventis Pharma is adding a syringe filling unit under insulator to its antiallergic and antithrombosis lab at Le Trait, in the Seine-Maritime departement of France. The French pharmaceutical firm is investing FFr 160mn in this operation.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

FRANCE: BIRTH OF LORRAINE PHARMA

Article Abstract:

Stephan Schommer is the manager of Lorraine Pharma, a new company created at Sierck-les-Bains in Moselle. It has a capital stock of EUR 50,000, and will specialises in large medications for humans.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: